MedTrace Logo

"Surgical Vs. Non-surgical Peri-implant Therapy"

NCT05168891 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-03-30

No results posted yet for this study

Summary

The aim of this randomized clinical trial is to evaluate the effectiveness, in terms of clinical and radiographic changes, of non-surgical peri-implant therapy (mechanical/chemical) versus regenerative surgical therapy (xenograft and collagen membrane), after a follow-up period of 12 months.

Conditions

  • Peri-Implantitis
  • Implant Complication
  • Bone Loss

Interventions

PROCEDURE

Surgical therapy

Peri-implantitis surgical therapy by means of open flap debridement, detoxification/decontamination of the implant surface and xenograft regeneration.

PROCEDURE

Non-surgical therapy of peri-implantitis

Peri-implant non-surgical therapy combined with antibiotic regimen consisting on metronidazole 500 mg every 8 hours for 7 days will be performed

Sponsors & Collaborators

  • Institut Straumann AG

    collaborator INDUSTRY

  • Universitat Internacional de Catalunya

    lead OTHER

Principal Investigators

  • Jose Nart, PhD · Universitat Internacional de Catalunya

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-20
Primary Completion
2022-02-20
Completion
2023-02-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05168891 on ClinicalTrials.gov